AI assistant
PFIZER INC — Director's Dealing 2023
Feb 25, 2023
29831_dirs_2023-02-24_d3cc1164-491f-443e-9a9d-70bd73589e0e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2023-02-22
Reporting Person: JOHNSON RADY A (Executive Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-02-22 | Common Stock | M | 31558.0000 | $30.1700 | Acquired | 106556.0000 | Direct |
| 2023-02-22 | Common Stock | F | 4526.0000 | $42.3800 | Disposed | 102030.0000 | Direct |
| 2023-02-22 | Common Stock | F | 19211.0000 | $43.7000 | Disposed | 82819.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-02-22 | Stock Appreciation Rights | $30.1700 | M | 31558.0000 | Disposed | 2023-02-22 | Common Stock (31558.0000) | Direct |
| 2023-02-23 | Stock Appreciation Rights | $42.3000 | A | 24797.0000 | Acquired | 2028-02-23 | Common Stock (24797.0000) | Direct |
| 2023-02-23 | Stock Appreciation Rights | $42.3000 | A | 21581.0000 | Acquired | 2030-02-23 | Common Stock (21581.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 5973.0000 | Indirect |
Footnotes
F1: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
F2: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
F3: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
F4: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
F5: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
F6: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.